Microbix Biosystems Inc.
MBXBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,688 | $3,472 | $5,325 | $6,044 |
| % Growth | -22.6% | -34.8% | -11.9% | – |
| Cost of Goods Sold | $1,599 | $2,057 | $2,156 | $2,291 |
| Gross Profit | -$1,261 | $1,415 | $3,168 | $3,753 |
| % Margin | -46.9% | 40.8% | 59.5% | 62.1% |
| R&D Expenses | -$30 | $592 | $510 | $600 |
| G&A Expenses | $0 | $1,754 | $2,025 | $1,816 |
| SG&A Expenses | -$281 | $2,153 | $2,480 | $2,183 |
| Sales & Mktg Exp. | $0 | $399 | $455 | $367 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | -$310 | $2,745 | $2,990 | $2,783 |
| Operating Income | -$951 | -$1,330 | $179 | $970 |
| % Margin | -35.4% | -38.3% | 3.4% | 16.1% |
| Other Income/Exp. Net | -$93 | -$313 | -$158 | -$113 |
| Pre-Tax Income | -$1,103 | -$1,643 | $21 | $857 |
| Tax Expense | -$40 | $0 | $0 | $0 |
| Net Income | -$1,063 | -$1,643 | $21 | $857 |
| % Margin | -39.5% | -47.3% | 0.4% | 14.2% |
| EPS | -0.006 | -0.012 | 0 | 0.006 |
| % Growth | 47.9% | -11,800% | -98.4% | – |
| EPS Diluted | -0.008 | -0.012 | 0 | 0.006 |
| Weighted Avg Shares Out | 139,253 | 140,581 | 139,847 | 134,914 |
| Weighted Avg Shares Out Dil | 139,253 | 140,609 | 140,617 | 137,628 |
| Supplemental Information | – | – | – | – |
| Interest Income | $54 | $69 | $93 | $118 |
| Interest Expense | $174 | $225 | $251 | $231 |
| Depreciation & Amortization | -$30 | $445 | $428 | $435 |
| EBITDA | -$943 | -$973 | $700 | $1,523 |
| % Margin | -35.1% | -28% | 13.1% | 25.2% |